CareFusion Updates Labeling For ChloraPrep® Products

             CareFusion Updates Labeling For ChloraPrep® Products

Important Information For Clinicians About Dry Time Directions

PR Newswire

SAN DIEGO, Nov. 12, 2013

SAN DIEGO, Nov. 12, 2013 /PRNewswire/ -- CareFusion (NYSE:CFN), a leading
global medical technology company, today announced it has received FDA
approval to update labeling with reduced dry times as part of the directions
for use on certain of its ChloraPrep^® products.

The reduced dry times apply to a number of CareFusion ChloraPrep products used
in skin preparation, including Sepp^®, Frepp^®, Single and Triple Swabsticks.
These applicators are no longer labeled for electrocautery procedures and have
a reduced dry time on dry surgical sites of 30 seconds and a dry time on moist
surgical sites of one minute.

Labeling for the ChloraPrep^® 3mL applicators has also been updated to include
dry time changes to  30 seconds for dry sites and one minute for moist sites 
for procedures not using an ignition source. The required dry times for
procedures that use an ignition source remain unchanged at a minimum of three
minutes on hairless skin and and up to one hour in hair.

Labeling for the ChloraPrep^® 10.5mL and 26mL applicators remains unchanged.

To view the complete updated labels and other important information about
ChloraPrep^®, visit
Additional questions about the updated labeling should be directed to
CareFusion Customer Support at 1-800-523-0502.

About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care
industry with products and services that help hospitals measurably improve the
safety and quality of care. The company develops industry-leading technologies
including Alaris^® infusion pumps, Pyxis^® automated dispensing and patient
identification systems, AVEA^®, AirLife^® and LTV^® series ventilation and
respiratory products, ChloraPrep^® products, MedMined^® services for data
mining surveillance, V. Mueller^® surgical instruments, and an extensive line
of products that support interventional medicine. CareFusion employs
approximately 15,000 people across its global operations. More information may
be found at


SOURCE CareFusion Corporation

Contact: Media, Troy Kirkpatrick, (858) 617-2361,, Investors, Jim Mazzola, (858) 617-1203,
Press spacebar to pause and continue. Press esc to stop.